glp 1 agonist eli lilly FDA just approved orforglipron (Foundayo), Lilly's oral GLP-1 receptor for obesity. In the ATTAIN-1 phase 3 trial (n=3,127), published in the New England Journal of Medicine, patients on the highest Lilly's Triple Agonist Retatrutide Holds

The is used for anti-aging, glowing skin, reducing wrinkles and inflammation, and enriching the skin with the nourishment of vitamins and minerals

### Benefits: Brightens Skin For A Radiant, Luminous Complexion

In this study, C57BL/6 mice treated for back hair removal were administered anwuligan via gavage at doses of 0 mg/kg, 1 mg/kg, 2 mg/kg, and 4 mg/kg, and hair growth on the backs of C57BL/6 mice was observed 14 days after gavage

MenoFlash Rhubarb (Rheum rhabarbarum) root tincture by Nutritional Frontiers

The PICRUSt2-based functional predictions provide insights into the microbial communitys functional capabilities by assessing the composition and abundance of functional attributes

Possible concerns may include injection-site irritation, headache, fatigue, digestive changes, immune response, allergic reaction, or symptom flares